Jun 02, 2021 / 12:00PM GMT
Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division - Senior Research Analyst
Hi, everybody, and thank you for joining us today to the first presentation of the SDC. We're very pleased to have with us Len Schleifer, Co-Founder, President and CEO of Regeneron; Bob Landry, Regeneron's CFO; and Justin Holko, who runs the IR Group.
So thank you all for joining us today. And Justin, why won't you -- we discussed that you will start with a few words, and then Len and I do -- will do a bit of a Q&A. Go ahead.
Justin Holko - Regeneron Pharmaceuticals, Inc. - VP of IR
Thank you, Ronny. Before we begin, I'd like to remind you that remarks made on today's webcast will include forward-looking statements by Regeneron. Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in that statement. A more complete description of these and other material risks can be found in Regeneron's SEC filings. We do not undertake any obligation to update any forward
Regeneron Pharmaceuticals Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript
Jun 02, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers